Neutron instrument BioRef arrived safely in Down Under
The SPATZ team of ANSTO was glad about the arrival of the former HZB neutron instrument BioRef. It will be set up until 2018 in Australia. photo: ANSTO.
As reported, the neutron instrument BioRef will be set up at the “Australian Centre for Neutron Scattering” of ANSTO. Approximately 257 components were safely packed in 43 wooden crates weighing just under 30 tonnes for the sea voyage from Hamburg to Port Botany, Australia. On 14 February the colleagues from ANSTO told us: the three shipping containers arrived safely after a two-month journey from Germany.
The ship transporting the packaged crates stopped at seven ports on the 45-day voyage which covered over 11,800 nautical miles.
ANSTO and HZB negotiated the transfer of the instrument from the BER-II Research Reactor at Helmholtz-Zentrum Berlin (HZB) and renewed a MOU for scientific collaboration with the renowned German research organisation in 2016. The instrument will be set up at the Australian Centre for Neutron Scattering (ACNS) until 2018. The new name is SPATZ, the German word for sparrow. It follows the tradition of the naming convention of other instruments at the Australian Centre for Neutron Scattering, which are named after Australian and other fauna. SPATZ will be available for user from Germany, too.
Read more here
- Key technology for a future without fossil fuelsIn June and July 2025, catalyst researcher Nico Fischer spent some time at HZB. It was his sabbatical, he was relieved of his duties as Director of the Catalysis Institute in Cape Town for several months and was able to focus on research only. His institute is collaborating with HZB on two projects that aim to develop environmentally friendly alternatives using innovative catalyst technologies. The questions were asked by Antonia Rötger, HZB.
- 5000th patient treated with protons for eye tumoursFor more than 25 years, Charité – Universitätsmedizin Berlin and the Helmholtz-Zentrum Berlin (HZB) have been jointly offering proton radiation therapy for eye tumours. The HZB operates a proton accelerator in Berlin-Wannsee for this purpose, while Charité provides medical care for the patients. The 5000th patient was treated at the beginning of August.
- Iridium-free catalysts for acid water electrolysis investigatedHydrogen will play an important role, both as a fuel and as a raw material for industry. However, in order to produce relevant quantities of hydrogen, water electrolysis must become feasible on a multi-gigawatt scale. One bottleneck is the catalysts required, with iridium in particular being an extremely rare element. An international collaboration has therefore investigated iridium-free catalysts for acidic water electrolysis based on the element cobalt. Through investigations with various methods, among them experiments at the LiXEdrom at the BESSY II X-ray source in Berlin, they were able to elucidate processes that take place during water electrolysis in a cobalt-iron-lead oxide material as the anode. The study is published in Nature Energy.